Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.01M

combined est. value

Stock	Shares	Price	Value	Weight	As of
QCLSQ/C TECHNOLOGIES, INC.	100,029	$3.61	$361.1K	36%	2025-11-14
TAOXTAO Synergies Inc.	86,681	$3.79	$328.5K	33%	2025-10-17
PMCBPharmaCyte Biotech, Inc.	416,250	$0.7709	$320.9K	32%	2026-01-07

QCLS

Q/C TECHNOLOGIES, INC.

$361.1K

100,029 sh

TAOX

TAO Synergies Inc.

$328.5K

86,681 sh

PMCB

PharmaCyte Biotech, Inc.

$320.9K

416,250 sh

Activity

Open-market buy & sell volume

BuySell

Total +$80.5K bought

Most bought

PMCB

$80.5K

All filings on record

Every Form 4 transaction we track for this filer

all 11buys 3sells 0

Stock	Transaction	Date	~6mo later
PMCBPharmaCyte Biotech, Inc.	Buy $33.3K · 40,000 sh	2026-01-07	in progress
PMCBPharmaCyte Biotech, Inc.	Buy $23.7K · 30,000 sh	2026-01-06	in progress
PMCBPharmaCyte Biotech, Inc.	Buy $23.5K · 30,000 sh	2026-01-05	in progress
PMCBPharmaCyte Biotech, Inc.	Tax $263.9K · 258,750 sh	2025-12-12	—
PMCBPharmaCyte Biotech, Inc.	Grant — · 575,000 sh	2025-12-12	—
QCLSQ/C TECHNOLOGIES, INC.	Grant — · 91,356 sh	2025-11-14	—
TAOXTAO Synergies Inc.	Tax $289.2K · 40,000 sh	2025-10-17	—
TAOXTAO Synergies Inc.	Grant — · 100,000 sh	2025-10-17	—
QCLSQ/C TECHNOLOGIES, INC.	Grant — · 8,644 sh	2025-10-03	—
TAOXTAO Synergies Inc.	Tax $131.6K · 16,768 sh	2025-06-30	—
TAOXTAO Synergies Inc.	Grant — · 41,919 sh	2025-06-30	—

PMCBBuy

2026-01-07 · PharmaCyte Biotech, Inc.

$33.3K

in progress

PMCBBuy

2026-01-06 · PharmaCyte Biotech, Inc.

$23.7K

in progress

PMCBBuy

2026-01-05 · PharmaCyte Biotech, Inc.

$23.5K

in progress

PMCBTax

2025-12-12 · PharmaCyte Biotech, Inc.

$263.9K

—

PMCBGrant

2025-12-12 · PharmaCyte Biotech, Inc.

575,000

—

QCLSGrant

2025-11-14 · Q/C TECHNOLOGIES, INC.

91,356

—

TAOXTax

2025-10-17 · TAO Synergies Inc.

$289.2K

—

TAOXGrant

2025-10-17 · TAO Synergies Inc.

100,000

—

QCLSGrant

2025-10-03 · Q/C TECHNOLOGIES, INC.

8,644

—

TAOXTax

2025-06-30 · TAO Synergies Inc.

$131.6K

—

TAOXGrant

2025-06-30 · TAO Synergies Inc.

41,919

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.